Recent Updates
-
NQF 0034 (Additional) Colorectal Cancer Screening
<p>Measure: NQF 0034 (Additional Measure) </p> <p>Measure Title: Colorectal Cancer Screening</p> <p>Measure Description: Percentage of patient's 50-75 years of age whom had at least one face-to-encounter and appropriate screening for colorectal cancer. </p> <p>*REQUIRED FOR MEANINGFUL USE (MU... -
NQF 0043 (Additional) - Pneumonia Vaccination Status for Older Adults
<p>Measure: NQF 0043 (Additional Measure) </p> <p>Measure Title: Pneumonia Vaccination Status for Older Adults</p> <p>Measure Description: Percentage of patients 65 years of age and older whom have ever received a pneumococcal vaccine and have had at least one face-to-face encounter within the ... -
Installation Guides: DataServer, SOAPware & DataManager
-
Importing a SOAPware Chart
This lesson describes how to import a SOAPware chart from one database to another. This can be done for individual charts as well as a bulk of charts.
-
Exporting a SOAPware Chart
This lesson will walk the user through the steps to export a chart from SOAPware in a format that allows the user to import it into another SOAPware database.
-
NQF 0070 (Additional) - Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI)
<p>Measure: NQF 0070 (Additional Measure)</p> <p>Measure Title: Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI)</p> <p>Measure description: Percentage of patients aged 18 years and older with a diagnosis of CAD and prior MI who were pre... -
NQF 0059/PQRI 1 (Additional) - Diabetes: Hemoglobin A1c Poor Control
<p>Measure: NQF 0059 (Additional Measurement)</p> <p>Measure: Diabetes: HbA1c Poor Control</p> <p>Measure Description: The percentage of patients 18–75 years of age with diabetes (type 1 or type 2) who had HbA1c >9.0%.</p> <p>*REQUIRED FOR MEANINGFUL USE (MU) CORE REQUIREMENT - Click here t... -
NQF 0081/PQRI 5 (Additional) - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
Updated on: Dec 07, 2022
-
Archived Meaningful Use Manuals Clinical Quality Measures User Guide (for 2011) Additional Measures (Choose 3 Additional Measures) NQF 0081/PQRI 5 (Additional) - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
<p>Measure: NQF 0081 (Additional Measurement)</p> <p>Measure Title: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD</p> <p>Measure Description: Percentage of patients aged 18 years an... -
-
NQF 0061/PQRI 3 (Additional)- Diabetes: Blood Pressure Management
<p>Measure: NQF 0061 (Additonal Measurement)</p> <p>Measure Title: Diabetes: Blood Pressure Management</p> <p>Measure Description: The percentage of patients 18–75 years of age with diabetes (type 1 or type 2) who had BP <140/90 mmHg.</p> <p>*REQUIRED FOR MEANINGFUL USE (MU) CORE REQUIREMEN... -
*NQF 0064 (Additional) - Diabetes: Low Density Lipoprotein (LDL) Management and Control
Measure: NQF 0064 (Additional Measure)
Measure Title: Diabetes: Low Density Lipoprotein (LDL) Management and Control
Measure Description: The percentage of patients 18-75 years of age with Diabetes (Type 1 or Type 2) who had LDL-Cholesterol < 100 mg/dL.